Genelux Corporation
GNLXNASDAQHealthcare● Active
$2.93
+$0.00(+0.00%)
Market Cap$110217535
P/E Ratio—
52W High$8.535
52W Low$2.29
Genelux Corporation (GNLX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GNLX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.01M | $0.01M | $0.17M | $11.07M | $0.00M |
| Cost of Revenue | $0.57M | $0.90M | $1.02M | $0.97M | $0.90M |
| Gross Profit | ($0.57M) | ($0.90M) | ($0.85M) | $10.10M | ($0.90M) |
| Gross Margin %(computed) | — | — | -498.82% | 91.25% | — |
| Operating Expenses | |||||
| R&D Expenses | $19.85M | $19.00M | $12.77M | $9.08M | $6.32M |
| G&A Expenses | $13.37M | $12.71M | $11.57M | $5.00M | $8.29M |
| Total Operating Expenses | $32.65M | $30.80M | $23.32M | $13.11M | $13.72M |
| Operating Income | ($33.21M) | ($31.70M) | ($24.16M) | ($3.01M) | ($14.61M) |
| Operating Margin %(computed) | — | — | — | -27.22% | — |
| Interest Income | $1.07M | $1.46M | $0.24M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $3.97M | $1.41M | $1.81M |
| Income Before Tax | ($32.15M) | ($29.87M) | ($28.30M) | ($4.11M) | ($16.38M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $1.10M | $0.00M |
| Net Income | ($32.15M) | ($29.87M) | ($28.30M) | ($5.21M) | ($17.80M) |
| Net Margin %(computed) | — | — | — | -47.05% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.86 | $-0.95 | $-1.16 | $-0.21 | $-0.69 |
| Wtd Avg Shares | 37.18M | 31.45M | 24.43M | 24.55M | 23.62M |
| EBITDA | ($32.64M) | ($28.97M) | ($26.46M) | ($1.73M) | ($13.67M) |
| EBITDA Margin %(computed) | — | — | — | -15.64% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Genelux Corporation data
About Genelux Corporation (GNLX) Income Statement
Genelux Corporation (GNLX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GNLX reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -7075.00%), and net income of ($0.03B) — a net profit margin of -401812.50%.
Frequently asked questions
GNLX · 4 questionsGenelux Corporation (GNLX) reported revenue of $0.00B for 2025, down 0.0% year-over-year.
GNLX revenueGNLX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08